CFD
KYNB

Creative Financial Designs’s Kyntra Bio KYNB Stock Holding History

Creative Financial Designs’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-11
Closed -$3K – 1294
2021
Q3 		$3K Hold
11
– – ﹤0.01% 1244
2021
Q2 		$7K Hold
11
– – ﹤0.01% 1084
2021
Q1 		$10K Hold
11
– – ﹤0.01% 932
2020
Q4 		$10K Hold
11
– – ﹤0.01% 867
2020
Q3 		$12K Hold
11
– – ﹤0.01% 767
2020
Q2 		$11K Buy
+11
New +$10.2K ﹤0.01% 727

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Creative Financial Designs's KYNB Position: Q4 2021 in Review

Creative Financial Designs sold out of Kyntra Bio (KYNB) in Q4 2021, closing a stake of 11 shares — an estimated $3K sold.

Creative Financial Designs first reported a position in KYNB in Q2 2020 and held it in 6 quarters. The position peaked at $12K in Q3 2020. 162 funds tracked by Wall St. Rank hold KYNB as of Q4 2021.

  • Creative Financial Designs reported no remaining Kyntra Bio position as of Q4 2021 after selling out during the quarter.
  • Creative Financial Designs sold 11 Kyntra Bio shares in Q4 2021, an estimated $3K.
  • Creative Financial Designs first reported a position in Kyntra Bio in Q2 2020 and held it in 6 quarters.
  • Creative Financial Designs's Kyntra Bio position peaked at $12K in Q3 2020.
  • 162 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2021.

Based on Creative Financial Designs's 13F filing for Q4 2021, filed 26 Jan 2022.